What are the recommended initial medications for treating hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Medications for Treating Hypertension

For most adults with hypertension, initial treatment should include a combination of an ACE inhibitor or ARB with either a thiazide/thiazide-like diuretic or a dihydropyridine calcium channel blocker. 1

First-Line Medication Classes

Both the European Society of Cardiology (ESC) and American College of Cardiology/American Heart Association (ACC/AHA) guidelines recommend the following drug classes as first-line treatments for hypertension:

  • ACE inhibitors (e.g., lisinopril)
  • ARBs (e.g., losartan)
  • Thiazide/thiazide-like diuretics (e.g., chlorthalidone, indapamide, hydrochlorothiazide)
  • Dihydropyridine calcium channel blockers (e.g., amlodipine)

These four classes have demonstrated the most effective reduction in blood pressure and cardiovascular disease events 1.

Initial Treatment Algorithm

Step 1: Assess Severity of Hypertension

  • For BP 130-139/80-89 mmHg: Start with lifestyle modifications for up to 3 months before considering medication 1
  • For BP 140-159/90-99 mmHg: Start with single agent or combination therapy 1
  • For BP ≥160/100 mmHg or BP >20/10 mmHg above target: Start with combination therapy 1

Step 2: Select Initial Medication Based on Patient Characteristics

Patient Characteristic Recommended Initial Treatment
Most patients ACE inhibitor/ARB + diuretic or CCB [1]
Black patients Thiazide diuretic or CCB [1]
Patients with albuminuria/CKD ACE inhibitor or ARB [1]
Patients with diabetes ACE inhibitor or ARB [1,2]
Patients with heart failure ACE inhibitor or ARB [1]

Medication Specifics

Thiazide/Thiazide-like Diuretics

  • Preferred agent: Chlorthalidone (12.5-25 mg daily) due to longer duration of action and stronger evidence in landmark trials 1, 2
  • Alternative: Hydrochlorothiazide (12.5-25 mg daily) 3, 4
  • Benefits: Low-dose thiazides effectively reduce BP while minimizing metabolic side effects 4, 5

ACE Inhibitors

  • Example: Lisinopril starting at 10 mg daily, usual range 20-40 mg 6
  • Benefits: Particularly beneficial in patients with diabetes, albuminuria, heart failure 1

ARBs

  • When to use: Alternative to ACE inhibitors when not tolerated (e.g., cough) 1

Calcium Channel Blockers

  • When to use: Particularly effective in black patients and elderly patients 1

Combination Therapy Approach

The 2024 ESC guidelines strongly recommend:

  • Initial combination therapy for most patients with confirmed hypertension (BP ≥140/90 mmHg)
  • Preferred combinations: ACE inhibitor/ARB + dihydropyridine CCB or diuretic 1
  • Single-pill combinations to improve adherence 1

Special Considerations

Compelling Contraindications

  • Avoid ACE inhibitors/ARBs in pregnancy or women planning pregnancy 2
  • Avoid combining ACE inhibitors with ARBs 1

Monitoring

  • For patients on ACE inhibitors, ARBs, or diuretics, monitor serum creatinine, eGFR, and potassium at least annually 1, 7
  • Monitor for electrolyte disturbances, particularly with diuretics (hypokalemia, hypomagnesemia) 7

Resistant Hypertension

If BP not controlled on three medications including a diuretic, consider adding spironolactone as fourth-line therapy 1.

Treatment Targets

  • General target: <130/80 mmHg for most patients 1, 2
  • Elderly patients (65-79 years): 130-139/80 mmHg 2
  • Very elderly (≥80 years): 140-150/<80 mmHg 2

The choice of initial antihypertensive medication should be guided by efficacy, tolerability, and specific patient characteristics, with the ultimate goal of reducing morbidity, mortality, and improving quality of life.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hypertension Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Evidence for the efficacy of low-dose diuretic monotherapy.

The American journal of medicine, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.